Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Shares Issued (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Shares Issued for 5 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 90.14% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.9 million through Dec 2025, down 74.81% year-over-year, with the annual reading at $5.9 million for FY2025, 74.81% down from the prior year.
  • Shares Issued for Q4 2025 was $2.3 million at Werewolf Therapeutics, down from $3.3 million in the prior quarter.
  • The five-year high for Shares Issued was $111.6 million in Q2 2021, with the low at -$21.0 million in Q3 2024.
  • Average Shares Issued over 5 years is $10.4 million, with a median of $612000.0 recorded in 2024.
  • The sharpest move saw Shares Issued plummeted 5294.97% in 2023, then surged 48858.33% in 2024.
  • Over 5 years, Shares Issued stood at $111.6 million in 2021, then plummeted by 99.77% to $254000.0 in 2022, then plummeted by 81.1% to $48000.0 in 2023, then soared by 48858.33% to $23.5 million in 2024, then plummeted by 90.14% to $2.3 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $2.3 million, $3.3 million, and $347000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.